镰状细胞血红蛋白病患者的视盘周围视网膜神经纤维层纵向变薄研究
结果显示视盘周围视网膜神经纤维层(RNFL)整体厚度以每年0.98μm的速度变薄,卒中史与更快的变薄速率相关,而高血压史与更慢的变薄速率相关。
要点
- 镰状细胞血红蛋白病患者视盘周围RNFL整体厚度平均每年减少0.98μm。
- 有卒中史的患者RNFL变薄速率更快(1.72±0.20 vs 0.79±0.12μm/年,P<.001)。
- 有高血压史的患者RNFL变薄速率更慢(0.33±0.27 vs 1.14±0.12μm/年,P=.002)。
核心结论
- 镰状细胞血红蛋白病患者视盘周围RNFL厚度随时间变薄,有卒中史者变薄更快,有高血压史者变薄更慢。
主要发现
- 122只眼平均随访3.8±2.0年(范围1-8年),基线整体视盘周围RNFL平均厚度为100.9±13.0μm。
- 整体视盘周围RNFL厚度以每年0.98μm的速度下降(95%CI 0.77-1.19μm/年)。
- 有卒中史者整体RNFL变薄速率为1.72±0.20μm/年,无卒中史者为0.79±0.12μm/年(P<.001)。
- 有高血压史者整体RNFL变薄速率为0.33±0.27μm/年,无高血压史者为1.14±0.12μm/年(P=.002)。
关键数值与推荐
- 排除标准包括糖尿病史、未控制的高血压、青光眼、屈光间质混浊、其他视网膜病变及既往视网膜手术史。
- 使用谱域光学相干断层扫描(Heidelberg Engineering, Inc)测量视盘RNFL厚度,线性混合模型估计变薄速率。
临床怎么用
- 对镰状细胞血红蛋白病患者进行纵向RNFL监测时,应关注卒中史和高血压史对变薄速率的影响。
局限性
- 未来研究需将这些速率与年龄和种族匹配的健康个体进行比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the rate of retinal nerve fiber layer (RNFL) thinning in patients with sickle cell hemoglobinopathies. DESIGN: This was a prospective cohort study. METHODS: Sixty-seven patients averaging 35.8 ± 11.5 years of age at enrollment with electrophoretically confirmed sickle cell hemoglobinopathies followed by the University of Illinois at Chicago retina clinic for ≥1 year were included. Exclusion criteria included a history of diabetes, uncontrolled hypertension, glaucoma, ocular opacities, other retinopathies, and previous retinal procedures. The optic nerve head RNFL thicknesses were measured with spectral-domain optical coherence tomography (Heidelberg Engineering, Inc) at enrollment and subsequent follow-ups. Linear mixed models were used to estimate rates of thinning. RESULTS: A total of 122 eyes were followed for 3.8 ± 2.0 years (range 1-8 years). Mean global peripapillary RNFL thickness was 100.9 ± 13.0 μm at baseline. Global peripapillary RNFL thickness decreased at a rate of 0.98 μm per year (95% confidence interval [CI] 0.77-1.19 μm/year). A history of stroke was associated with a faster rate of global RNFL thinning (1.72 ± 0.20 vs 0.79 ± 0.12 μm/year, P < .001), whereas a history of hypertension was associated with a slower rate of thinning (0.33 ± 0.27 vs 1.14 ± 0.12 μm/year, P = .002). CONCLUSIONS: Peripapillary RNFL thinning in patients with sickle cell hemoglobinopathies occurred faster in patients with a history of stroke and slower in patients with controlled hypertension. Future studies will compare these rates to those of healthy age- and race-matched individuals.
引用
- Thavikulwat AT, Cao D, Vajaranant TS, et al. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies. Am J Ophthalmol. 2019. PMID: 30771331. doi:10.1016/j.ajo.2019.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。